Table 4.
Univariate and multivariate relative risks for recurrence of cardiovascular disease in the different cohorts
Outcome predictor | Univariate | Multivariate§ | ||
---|---|---|---|---|
RR | 95% CI | RR | 95% CI | |
Aspirin-alone cohort | ||||
Adherence to aspirin (%) | ||||
<80 | 1.00 | 1.00 | ||
80–100 | 1.14 | 1.04, 1.24 | 1.08 | 0.97, 1.21† |
Statin-alone cohort | ||||
Adherence to statin (%) | ||||
<80 | 1.00 | 1.00 | ||
80–100 | 0.83 | 0.61, 1.12 | 0.66 | 0.47, 0.91* |
Combination cohort | ||||
Adherence to both (%) | ||||
Both <80% | 1.00 | 1.00 | ||
Statin ≥80% and aspirin <80% | 0.67* | 0.52, 0.86 | 0.64 | 0.49, 0.82** |
Statin <80% and aspirin ≥80% | 0.93 | 0.74, 1.18 | 0.91 | 0.72, 1.15 |
Both ≥80% | 0.82* | 0.68, 0.99 | 0.69 | 0.56, 0.84** |
Adjusted for age, gender, social deprivation, calendar year, diabetes mellitus, cardiovascular drug use during follow-up and number of cardiovascular prescriptions.
Also adjusted for interaction between aspirin adherence and nonsteroidal anti-inflammatory drug use.
P < 0.05;
P < 0.01.